MIST (Milestone Pharmaceuticals) Institutional Ownership: 23.93% (As of Jul. 07, 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.29
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals Institutional Ownership?

Milestone Pharmaceuticals MIST -2.27% 26 Institutional Ownership is 23.93% as of Jul. 07, 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Milestone Pharmaceuticals's institutional ownership is 23.93%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Milestone Pharmaceuticals's Insider Ownership is 2.82%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Milestone Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.29%.

Milestone Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals Institutional Ownership Chart

Milestone Pharmaceuticals Historical Data

The historical data trend for Milestone Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 3.47 3.47 3.47 1.64 1.53 1.53 1.37 2.94 2.78 2.74
MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 23.93% mean?
Milestone Pharmaceuticals (MIST) has a Institutional Ownership of 23.93% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Milestone Pharmaceuticals and its competitors.
Is Milestone Pharmaceuticals' Institutional Ownership too high?
Milestone Pharmaceuticals' current Institutional Ownership is 23.93%. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' Institutional Ownership compare to TNYA and TLSA?
Milestone Pharmaceuticals' Institutional Ownership of 23.93% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current Institutional Ownership is 23.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current Institutional Ownership of 23.93%. The current Institutional Ownership is 23.93%. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current Institutional Ownership is 23.93% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.29
Price